SG10201913822PA - Methods for treating atopic dermatitis by administering an il-4r antagonist - Google Patents
Methods for treating atopic dermatitis by administering an il-4r antagonistInfo
- Publication number
- SG10201913822PA SG10201913822PA SG10201913822PA SG10201913822PA SG10201913822PA SG 10201913822P A SG10201913822P A SG 10201913822PA SG 10201913822P A SG10201913822P A SG 10201913822PA SG 10201913822P A SG10201913822P A SG 10201913822PA SG 10201913822P A SG10201913822P A SG 10201913822PA
- Authority
- SG
- Singapore
- Prior art keywords
- antagonist
- administering
- methods
- atopic dermatitis
- treating atopic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
- G01N2800/202—Dermatitis
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261697972P | 2012-09-07 | 2012-09-07 | |
US201261738715P | 2012-12-18 | 2012-12-18 | |
US201361748588P | 2013-01-03 | 2013-01-03 | |
US201361764624P | 2013-02-14 | 2013-02-14 | |
US201361768229P | 2013-02-22 | 2013-02-22 | |
US201361770091P | 2013-02-27 | 2013-02-27 | |
US201361782420P | 2013-03-14 | 2013-03-14 | |
US201361816191P | 2013-04-26 | 2013-04-26 | |
FR1356759 | 2013-07-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201913822PA true SG10201913822PA (en) | 2020-03-30 |
Family
ID=67734429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201913822PA SG10201913822PA (en) | 2012-09-07 | 2013-09-04 | Methods for treating atopic dermatitis by administering an il-4r antagonist |
Country Status (8)
Country | Link |
---|---|
JP (2) | JP6901545B2 (en) |
KR (1) | KR102284244B1 (en) |
HK (1) | HK1251896A1 (en) |
IL (2) | IL266941A (en) |
MX (1) | MX2019002801A (en) |
PT (1) | PT2892927T (en) |
SG (1) | SG10201913822PA (en) |
TW (1) | TWI790457B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111518211B (en) * | 2018-12-25 | 2022-06-21 | 江苏荃信生物医药股份有限公司 | Pharmaceutical application of human interleukin 4receptor alpha monoclonal antibody |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7608693B2 (en) * | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
-
2013
- 2013-09-04 PT PT137658449T patent/PT2892927T/en unknown
- 2013-09-04 KR KR1020207016390A patent/KR102284244B1/en active IP Right Grant
- 2013-09-04 SG SG10201913822PA patent/SG10201913822PA/en unknown
- 2013-09-05 TW TW109123001A patent/TWI790457B/en active
-
2015
- 2015-03-05 MX MX2019002801A patent/MX2019002801A/en unknown
-
2018
- 2018-08-31 HK HK18111216.5A patent/HK1251896A1/en unknown
-
2019
- 2019-05-28 IL IL266941A patent/IL266941A/en active IP Right Grant
- 2019-12-18 JP JP2019227843A patent/JP6901545B2/en active Active
-
2020
- 2020-11-25 IL IL278968A patent/IL278968B/en unknown
-
2021
- 2021-06-16 JP JP2021099837A patent/JP7256231B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
MX2019002801A (en) | 2019-07-15 |
IL278968B (en) | 2021-09-30 |
TW202041536A (en) | 2020-11-16 |
JP6901545B2 (en) | 2021-07-14 |
HK1251896A1 (en) | 2019-04-26 |
JP7256231B2 (en) | 2023-04-11 |
TWI790457B (en) | 2023-01-21 |
JP2020059749A (en) | 2020-04-16 |
JP2021152042A (en) | 2021-09-30 |
KR102284244B1 (en) | 2021-08-03 |
IL278968A (en) | 2021-01-31 |
PT2892927T (en) | 2018-08-02 |
IL266941A (en) | 2019-07-31 |
KR20200069388A (en) | 2020-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181227T1 (en) | Methods for treating atopic dermatitis by administering an il-4r antagonist | |
HRP20181963T1 (en) | Methods for treating or preventing asthma by administering an il-4r antagonist | |
HK1222567A1 (en) | Methods for treating nasal polyposis by administering an il-4r antagonist il-4r | |
ZA201906339B (en) | Methods for treating pruritus | |
ZA201407459B (en) | Method and apparatus for subscription sharing | |
EP2851378A4 (en) | Method for producing oxymethylene copolymer | |
IL278968B (en) | Methods for treating atopic dermatitis by administering an il-4r antagonist | |
HK1209040A1 (en) | Methods for treating vestibulotoxicity | |
IL271284A (en) | Methods for treating or preventing asthma by administering an il-4r antagonist | |
EP2736517A4 (en) | Pharmaceutical composition for treating atopic dermatitis | |
HUE046410T2 (en) | Methods for treating nasal polyposis by administering an il-4r antagonist |